Ankerstar Wealth’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Ankerstar Wealth's TGTX Position: Q3 2026 in Review
Ankerstar Wealth held its TG Therapeutics (TGTX) position steady in Q3 2026 at 30 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #441.
Ankerstar Wealth first reported a position in TGTX in Q4 2025 and has held it in 4 quarters since. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Ankerstar Wealth held 30 shares of TG Therapeutics worth $1.67K as of Q3 2026.
- Ankerstar Wealth left its TG Therapeutics share count unchanged in Q3 2026.
- TG Therapeutics made up ﹤0.01% of Ankerstar Wealth's portfolio in Q3 2026, its #441 holding.
- Ankerstar Wealth first reported a position in TG Therapeutics in Q4 2025 and has held it in 4 quarters since.
- 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.